IPP Bureau
Lupin enters into agreement with Lilly to expand access for COVID-19
By IPP Bureau - May 10, 2021
Baricitinib is an oral medication that was earlier registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.
Zydus Wellness reports Rs. 133.13 Cr consolidated PAT in Q4FY21
By IPP Bureau - May 10, 2021
Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in-their respective categories as on March 2021.
Roche receives emergency use authorisation of COVID-19 drug
By IPP Bureau - May 07, 2021
This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India
Lonza announces expansion plans for mammalian manufacturing facilities
By IPP Bureau - May 07, 2021
The facility is expected to be completed in 2024
PerkinElmer to donate 1 million rapid COVID-19 antigen test kits in India
By IPP Bureau - May 07, 2021
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
Alembic announces USFDA approval for two drugs
By IPP Bureau - May 06, 2021
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA
Govt. allocates 16.5 lakh vials of Remdesivir between May 3-9
By IPP Bureau - May 06, 2021
Seven manufacturers of Remdesivir have increased production capacity to 1.03 crore vials per month up from 38 lakh vials per month a month ago
Morepen Laboratories net profit up 189%
By IPP Bureau - May 05, 2021
R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
Natco receives emergency use approval for Baricitinib tablets
By IPP Bureau - May 05, 2021
The company will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic
Govt. gives order for 16 cr COVID-19 vaccine doses
By IPP Bureau - May 04, 2021
As of 2nd May 2021, the Government has provided more 16.54 crore COVID-19 vaccine doses to States/UTs free of cost
Glenmark launches Ryaltris-AZ at affordable price
By IPP Bureau - May 04, 2021
First company in the world to launch Ryaltris-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg
RPG Life Sciences reports Rs. 6.92 crore PAT in Q4 FY2020-21
By IPP Bureau - May 03, 2021
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr
By IPP Bureau - May 03, 2021
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
Gujarat Themis Biosyn Q4FY21 net profit lower at Rs. 5.79 Cr
By IPP Bureau - May 03, 2021
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
India to import 450,000 vials of Remdesivir
By IPP Bureau - May 01, 2021
The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country
